Schreiber, C A <br/><br/>
The antiviral agents, MAP30 and GAP31, are not toxic to human spermatozoa and may be useful in preventing the sexual transmission of human immunodeficiency virus type 1.  [electronic resource] 

 -  Fertility and sterility  Oct 1999 
 - 686-90 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0015-0282 
<br/><br/><label>Standard No.: </label>10.1016/s0015-0282(99)00302-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-HIV Agents--pharmacology<br/>Cell Survival<br/>HIV Infections--prevention & control<br/>HIV-1--drug effects<br/>Humans<br/>Male<br/>Nonoxynol--pharmacology<br/>Plant Proteins--pharmacology<br/>Prospective Studies<br/>Ribosome Inactivating Proteins, Type 1<br/>Ribosome Inactivating Proteins, Type 2<br/>Sexually Transmitted Diseases, Viral--prevention & control<br/>Sperm Motility--drug effects<br/>Spermatocidal Agents--pharmacology<br/>Spermatozoa--drug effects<br/>Staining and Labeling